Single Dose Reverses Autism-like Symptoms in Mice

Old drug used for sleeping sickness may point to new treatment in humans

In a further test of a novel theory that suggests autism is the consequence of abnormal cell communication, researchers at the University of California, San Diego School of Medicine report that an almost century-old drug approved for treating sleeping sickness also restores normal cellular signaling in a mouse model of autism, reversing symptoms of the neurological disorder in animals that were the human biological age equivalent of 30 years old. … Read the full story from the UC San Diego Newsroom

$1 Million Gift from Joan and Irwin Jacobs Supports New Center for Personalized Cancer Therapy

A leadership gift of $1 million from San Diego philanthropists Joan and Irwin Jacobs will help UC San Diego Moores Cancer Center change how cancer is treated by supporting the Center for Personalized Cancer Therapy, a newly established center headed by Razelle Kurzrock, M.D. The UC San Diego Moores Cancer Center is one of just 41 National Cancer Institute-designated Comprehensive Cancer Centers in the United States, and the only one in the San Diego region. … Read the full story from the UCSD Newsroom


Dr. Razelle KurzrockPhysician-scientist Razelle Kurzrock, MD, is Senior Deputy Director for Clinical Science at the Moores Cancer Center. There, she directs the Clinical Trials Office as well as the Center for Personalized Cancer Therapy.

Kurzrock is professor of medicine and vice chief of the Division of Hematology-Oncology at UC San Diego.